AnaptysBio Inc (ANAB)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Daniel R. Faga |
| Employees: | 100 |
| Web site: | anaptysbio.com |
|
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
858-362-6295
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
AnaptysBio, Inc. engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations.
Please log in first to see chart